Literature DB >> 8626006

The transmission dynamics of hepatitis B in the UK: a mathematical model for evaluating costs and effectiveness of immunization programmes.

J R Williams1, D J Nokes, G F Medley, R M Anderson.   

Abstract

Complex hepatitis B (HBV) epidemiology makes it difficult to evaluate and compare effectiveness of different immunization policies. A method for doing so is presented using a mathematical model of HBV transmission dynamics which can represent universal infant and adolescent vaccination strategies and those targeted at genito-urinary (GU) clinic attenders and infants born to infectious mothers. Model structure, epidemiological underpinning, and parameterization, are described. Data from the UK National Survey of Sexual Attitudes and Lifestyles is used to define patterns of sexual activity and GU clinic attendance; data deficiencies are discussed, in particular that of UK seroprevalence of HBV markers stratified by age, sex, and risk factors. General model predictions of endemic HBV marker prevalence in homosexual and heterosexual populations seem consistent with published UK data. The simulations exhibit non-linearities in the impact of different vaccination strategies. Estimated number of carriers prevented per vaccine dose for each strategy provides a measure of costs and benefits, varying temporally over the course of a programme, and with level of vaccine coverage. Screening before vaccination markedly increases payback per dose in homosexuals but not in heterosexuals; mass infant vaccination gives the poorest effectiveness ratio and vaccination of infants after antenatal screening the best; in general, increasing vaccine coverage yields lower pay-back per dose. The model provides a useful framework for evaluating costs and benefits of immunization programmes, but for precise quantitative comparison more UK epidemiological data is urgently needed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8626006      PMCID: PMC2271247          DOI: 10.1017/s0950268800058970

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  18 in total

1.  Retrospective study of HIV, hepatitis B, and HTLV-I infection at a London antenatal clinic.

Authors:  J E Banatvala; I L Chrystie; S J Palmer; A Kenney
Journal:  Lancet       Date:  1990-04-07       Impact factor: 79.321

2.  The long-term serological course of asymptomatic hepatitis B virus carriers and the development of primary hepatocellular carcinoma.

Authors:  W L Alward; B J McMahon; D B Hall; W L Heyward; D P Francis; T R Bender
Journal:  J Infect Dis       Date:  1985-04       Impact factor: 5.226

3.  Incidence and significance of hepatitis B core antibody in a healthy blood donor population.

Authors:  A D Kitchen; T J Harrison; T J Meacock; A J Zuckerman; J F Harrison
Journal:  J Med Virol       Date:  1988-05       Impact factor: 2.327

4.  Hepatitis B immune globulin as a prophylactic measure for spouses exposed to acute type B hepatitis.

Authors:  A G Redeker; J W Mosley; D J Gocke; A P McKee; W Pollack
Journal:  N Engl J Med       Date:  1975-11-20       Impact factor: 91.245

5.  A comparison of different methods of screening blood donations for HBsAg.

Authors:  J A Barbara; D R Howell; T E Cleghorn; C H Cameron; M Briggs; D S Dane
Journal:  Vox Sang       Date:  1977       Impact factor: 2.144

6.  Antenatal screening for hepatitis B is medically and economically effective in the prevention of vertical transmission: three years experience in a London hospital.

Authors:  M G Brook; A M Lever; D Kelly; D Rutter; R S Trompeter; P Griffiths; H C Thomas
Journal:  Q J Med       Date:  1989-04

7.  Frequency of asymptomatic hepatitis types B and C in an inner city community and relation to possible risk factors.

Authors:  R King; P J Johnson; Y S White; H M Smith; R Williams
Journal:  Q J Med       Date:  1991-08

8.  Transmission of HBsAg from mother to infant in four ethnic groups.

Authors:  A Derso; E H Boxall; M J Tarlow; T H Flewett
Journal:  Br Med J       Date:  1978-04-15

9.  Human immunodeficiency virus infection, hepatitis B virus infection, and sexual behaviour of women attending a genitourinary medicine clinic.

Authors:  B A Evans; S M McCormack; R A Bond; K D MacRae; R W Thorp
Journal:  Br Med J (Clin Res Ed)       Date:  1988-02-13

10.  Failure to deliver hepatitis B vaccine: confessions from a genitourinary medicine clinic.

Authors:  N Bhatti; R J Gilson; M Beecham; P Williams; M P Matthews; R S Tedder; I V Weller
Journal:  BMJ       Date:  1991-07-13
View more
  19 in total

1.  Optimal control for an age-structured model for the transmission of hepatitis B.

Authors:  Ramses Djidjou Demasse; Jean-Jules Tewa; Samuel Bowong; Yves Emvudu
Journal:  J Math Biol       Date:  2015-12-16       Impact factor: 2.259

Review 2.  Should universal hepatitis B immunisation be introduced in the UK?

Authors:  P English
Journal:  Arch Dis Child       Date:  2006-04       Impact factor: 3.791

3.  Targeted hepatitis B vaccination--a cost effective immunisation strategy for the UK?

Authors:  J R Williams; D J Nokes; R M Anderson
Journal:  J Epidemiol Community Health       Date:  1996-12       Impact factor: 3.710

4.  Vaccine coverage during a school-based hepatitis B immunization program.

Authors:  S L Deeks; I L Johnson
Journal:  Can J Public Health       Date:  1998 Mar-Apr

5.  Use of antiviral treatment and prophylaxis is unlikely to have a major impact on the prevalence of herpes simplex virus type 2.

Authors:  P J White; G P Garnett
Journal:  Sex Transm Infect       Date:  1999-02       Impact factor: 3.519

6.  Too much of a good thing? When to stop catch-up vaccination.

Authors:  David W Hutton; Margaret L Brandeau
Journal:  Med Decis Making       Date:  2013-07-15       Impact factor: 2.583

7.  The economic burden of hepatitis B in Germany.

Authors:  S Harbarth; T Szucs; K Berger; W Jilg
Journal:  Eur J Epidemiol       Date:  2000-02       Impact factor: 8.082

8.  Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment.

Authors:  Yan Liu; Felicia Wu
Journal:  Environ Health Perspect       Date:  2010-02-19       Impact factor: 9.031

9.  A dynamic transmission model for predicting trends in Helicobacter pylori and associated diseases in the United States.

Authors:  M F Rupnow; R D Shachter; D K Owens; J Parsonnet
Journal:  Emerg Infect Dis       Date:  2000 May-Jun       Impact factor: 6.883

10.  Hepatitis B virus infection in patients attending a genitourinary medicine clinic: risk factors and vaccine coverage.

Authors:  R J Gilson; A de Ruiter; J Waite; E Ross; C Loveday; D R Howell; R S Tedder; I V Weller
Journal:  Sex Transm Infect       Date:  1998-04       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.